Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1626 results

ShortCut leads the way for leaflet modification

14 May 2024 – From EuroPCR 2024

Check out this interview with Philippe Genereux, Danny Dvir and Susheel Kodali, where they discuss the ShortCut trial. Learn about the ShortCut device, the first tool for splitting leaflets in valve-in-valve procedures. Hear key insights, including the dual splitting technique, comparisons between BASILICA and ShortCut, and...

ShortCut leads the way

Innovations in transcatheter valve interventions: moving the flow in the right direction

13 May 2024 – From EuroPCR 2024

Innovations in transcatheter valve interventions: moving the flow in the right direction

Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry

15 Apr 2024

This trial sought to compare the procedural and clinical outcomes of ACURATE neo/neo2 and EVOLUT R/PRO/Pro+ valves for ViV procedures.

Reviewer

Leonidas Koliastasis
Nicola Ryan

Reviewer

Nicola Ryan
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry

Self-expanding versus balloon-expandable transcatheter aortic valve replacement in patients with small aortic annuli: Primary outcomes from the randomized SMART Trial

07 Apr 2024

Alessandro Sticchi interviews Howard C. Herrmann about the primary outcomes from the randomized SMART Trial which he presented at ACC.24 in Atlanta.

Patients with severe aortic stenosis and small aortic annuli, typically female and often underrepresented in clinical trials, are at risk for impaired valvular hemodynamics and associated...

Howard Herrmann

Author

Howard Herrmann
Alessandro Sticchi

Author

Alessandro Sticchi
Self-expanding vs balloon-expandable TAVR in patients with small aortic annuli: Smart Trial Primary outcomes

PCRonline @ ACC.24 Scientific Sessions

22 Mar 2024

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2024 Scientific Sessions #ACC24

PCRonline @ ACC.24 Scientific Sessions

Non–vitamin K antagonist versus vitamin K antagonist oral anticoagulant agents after transcatheter aortic valve replacement

19 Mar 2024

This study demonstrates that, at 5 years post TAVI in patients with an indication for OAC, the net clinical benefit did not differ between the VKA and DOAC groups.

Nicola Ryan

Reviewer

Nicola Ryan
Aleksandra Gasecka

Reviewer

Aleksandra Gasecka
Non–vitamin K antagonist vs vitamin K antagonist oral anticoagulant agents after TAVR

Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial

13 Mar 2024

The NOTION trial provides the first ten-year data comparing clinical outcomes and valve durability between TAVI and SAVR in the lower risk population.

Nicola Ryan

Reviewer

Nicola Ryan
Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial

TAVI versus SAVR in patients at low to intermediate risk: One year outcomes of the randomized DEDICATE-DZHK6 Trial

08 Apr 2024

Luigi Biasco interviews Moritz Seiffert about the one-year outcomes of the randomized DEDICATE-DZHK6 trial which he presented at ACC.24 in Atlanta.

TAVR was found non-inferior to SAVR in low-risk patients, showing decreased rates of death or stroke at one year. The trial supports TAVR's safety and efficacy, highlighting...

Luigi Biasco

Author

Luigi Biasco
Moritz Seiffert

Author

Moritz Seiffert
TAVI versus SAVR in patients at low to intermediate risk: One year outcomes of the randomized DEDICATE-DZHK6 Trial

Protein and exercise to reverse frailty in older men and women undergoing transcatheter aortic valve replacement: The PERFORM-TAVR Trial

08 Apr 2024

Panos Xaplanteris provides his take on the results of PERFORM-TAVR presented by Jonathan Afilalo at ACC.24 in Atlanta.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
PERFORM-TAVR: Protein and exercise to reverse frailty in older patients undergoing TAVR

Contemporary techniques for TAV-in-SAV interventions

18 Feb 2024 – From PCR Tokyo Valves 2024

Thanks to this session, take a look at the current outcomes of TAV-in-SAV, analyse the different types of valves and their fracturability, find out more, through case studies, about two different TAV-in-SAV techniques, with or without a stent, and learn how to avoid patient prosthesis mismatch...

Contemporary techniques for TAV-in-SAV interventions

Shaping the future of structural heart disease intervention

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session if you want to discuss the remaining challenges of transcatheter valvular interventions, and to review latest innovations for structural heart disease.

Shaping the future of structural heart disease intervention

TAVI and future coronary access - LIVE case

18 Feb 2024 – From PCR Tokyo Valves 2024

An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...

TAVI and future coronary access - LIVE case

Rapid-fire - Other SHD interventions

18 Feb 2024 – From PCR Tokyo Valves 2024

Structural heart disease might present unusual complications during intervention. In this series of rapid-fire case submissions, learn about intervention on a pregnant patient, complete heart block post TAVR, and TAVR on a nonagerian female.

CAD and TAVI

18 Feb 2024 – From PCR Tokyo Valves 2024

What is the clinical impact of CAD in TAVR recipients and how best to treat it? Through this session, gain insight on how to determine optimal CAD assessment in TAVR recipients, learn the timing of coronary revascularisation pre-TAVR, and understand the exact assessment and treatment of...

CAD and TAVI

TAVI optimisation

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this series of slides to enhance your understanding of TAVI optimisation through selected studies for PCR Tokyo Valves 2024. Learn about the prognostic value of right ventricle dysfunction after TAVR, explore a risk model in dialysis patients following TAVR, and explore the impact of age...

TAVI optimisation

Managing aortic stenosis in patients with longer life expectancy

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to understand what knowledge is needed for discussions with patients concerning lifetime management of valve disease, gain insight into the importance of predictable and precise commissural and coronary alignment for lifetime management, and learn about the indication of TAV-in-TAV and THV explant.

Rapid-fire - Outcome studies after valvular intervention

18 Feb 2024 – From PCR Tokyo Valves 2024

This session of rapid-fire submitted cases focuses on outcome studies after valvular intervention. Learn about clinical impacts of cerebral micro-bleeds in patients undergoing TAVI, explore the long-term outcomes of Venus P valve for dysfunctional right ventricular outflow tract, and more!

Learn the procedure technique - Lifetime management of aortic stenosis therapy with self-expandable valve

18 Feb 2024 – From PCR Tokyo Valves 2024

In this session, learn all about the excellent characteristics of the latest self-expandable valve system and its use during the lifetime management of aortic stenosis therapy. Find out more about how we can effectively and safely perform procedures for various cases with the latest self-expandable valve,...

TAVI in bicuspid anatomy

18 Feb 2024 – From PCR Tokyo Valves 2024

Delve into the complexities of TAVI within bicuspid anatomy through this selection of cases: learn about the challenges and techniques involved in overcoming the horizontal aorta, explore how to size  the transcatheter aortic valve in severely calcified bicuspid anatomy, and more!

Rapid-fire - Complex procedure in TAVI - Part 2

18 Feb 2024 – From PCR Tokyo Valves 2024

In the second part of this rapid-fire session, we continue to focus on complex cases that might arise during TAVI, such as a case of prosthetic aortic valve endocarditis resulting in cardiogenic shock,  treatment of severe AR after infective endocarditis, and more!